year, announced its 2022 financial results recently.
Rising consumer price inflation has exacerbated the ongoing challenge of medical schemes to remain affordable. The number of principal members has exceeded 353 763, with 727 041 beneficiaries at an average age of 35.5. Testimony to this is being awarded a Titanium Award from the Board of Healthcare Funders for ‘Operational Performance’ in May 2023 for the second year running.
The investment portfolio value for 2022 reached R9.97 billion. As a medical scheme we don’t have shareholders or investors who receive dividends, we exist and spend our funds purely for the benefit of our members.The Scheme’s approach to realigning Managed Care initiatives, with a particular focus on hospital negotiations, resulted in a projected negotiated savings of R260 million.Optimising and aligning networks is a key strategy for managing costs.
Deloitte conducted a Transactional and Relational Governance Review of years 2020 and 2021 with the results received in November 2022. However, Bonitas remains committed to deliver benefit enrichment for members, which we can do through our value-added offerings, healthy reserves and high solvency level.